TY - JOUR
T1 - Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases
T2 - Ph-negative and variant Ph-positive
AU - Yehuda, Orly
AU - Abeliovich, Dvorah
AU - Ben-Neriah, Susana
AU - Sverdlin, Ilana
AU - Cohen, Rachel
AU - Varadi, Gabor
AU - Orr, Reuven
AU - Ashkenazi, Yaacov J.
AU - Heyd, Judith
AU - Lugassy, Gilles
AU - Yehuda, Dina Ben
PY - 1999/10/15
Y1 - 1999/10/15
N2 - Thirteen chronic myeloid leukemia (CML) patients, 10 with variant Philadelphia (Ph) translocations and 3 Ph negative cases, were analyzed by fluorescence in situ hybridization (FISH) with the use of BCR and ABL cosmid probes and a chromosome 22 painting probe. In the variant Ph translocations, the BCR-ABL fusion gene was located on the Ph chromosome; in 1 CML Ph-negative patient, the BCR-ABL fusion gene was located on the Ph chromosome; and, in 2 patients, it was located on chromosome 9. The chromosome 22 painting probe was detected on the third-party chromosome of the variant translocation, and in none of the variant translocations was there any detectable signal on chromosome 9. In CML patients with clonal evolution of a simple Ph, a signal of the chromosome 22 painting probe was detected on the der(9) of the Ph translocation. It was concluded that the variant Ph translocations evolved simultaneously in a three-way rearrangement. The clinical parameters of the 13 patients were similar to those of a large group of CML patients with a simple Ph translocation. It is suggested that, to determine the prognosis of CML patients with a complex karyotype, FISH analysis with a chromosome 22 painting probe be performed. Copyright (C) 1999 Elsevier Science Inc.
AB - Thirteen chronic myeloid leukemia (CML) patients, 10 with variant Philadelphia (Ph) translocations and 3 Ph negative cases, were analyzed by fluorescence in situ hybridization (FISH) with the use of BCR and ABL cosmid probes and a chromosome 22 painting probe. In the variant Ph translocations, the BCR-ABL fusion gene was located on the Ph chromosome; in 1 CML Ph-negative patient, the BCR-ABL fusion gene was located on the Ph chromosome; and, in 2 patients, it was located on chromosome 9. The chromosome 22 painting probe was detected on the third-party chromosome of the variant translocation, and in none of the variant translocations was there any detectable signal on chromosome 9. In CML patients with clonal evolution of a simple Ph, a signal of the chromosome 22 painting probe was detected on the der(9) of the Ph translocation. It was concluded that the variant Ph translocations evolved simultaneously in a three-way rearrangement. The clinical parameters of the 13 patients were similar to those of a large group of CML patients with a simple Ph translocation. It is suggested that, to determine the prognosis of CML patients with a complex karyotype, FISH analysis with a chromosome 22 painting probe be performed. Copyright (C) 1999 Elsevier Science Inc.
UR - http://www.scopus.com/inward/record.url?scp=0032831959&partnerID=8YFLogxK
U2 - 10.1016/S0165-4608(99)00067-9
DO - 10.1016/S0165-4608(99)00067-9
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 10549264
AN - SCOPUS:0032831959
SN - 0165-4608
VL - 114
SP - 100
EP - 107
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 2
ER -